Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sustained Acoustic Medicine (SAM) for Symptomatic Treatment of Knee Pain Related to Osteoarthritis

NCT07515872 is registered in ClinicalTrials.gov with ZetrOZ, Inc. as lead sponsor.

NCT NCT07515872
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07515872 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sustained Acoustic Medicine (SAM) for Symptomatic Treatment of Knee Pain Related to Osteoarthritis
Lead sponsor
ZetrOZ, Inc.
Phase
Phase 2
Overall status
Not yet recruiting
Start date
May 1, 2026
Completion date
May 31, 2028
Enrollment
240 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

arthritis, osteo arthritis of the knee